Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hiep Nguyen, R. Dufour, Amanda Caldwell-Tarr (2017)
Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare PopulationAdvances in Therapy, 34
F. Pouwer, F. Snoek, H. Ploeg, R. Heine, Arie Brand (1998)
A comparison of the standard and the computerized versions of the Well-being Questionnaire (WBQ) and the Diabetes Treatment Satisfaction Questionnaire (DTSQ)Quality of Life Research, 7
L. Donnelly, A. Morris, J. Evans (2007)
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes.QJM : monthly journal of the Association of Physicians, 100 6
J. Thrasher (2017)
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.The American journal of medicine, 130 6S
S. Brunton, J. Davidson (2016)
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes.Clinical therapeutics, 38 3
A. Hauber, bullet Kaan, Tunceli bullet, Jui-Chen Yang, bullet Ira, Gantz bullet, K. Brodovicz, C. Alexander, M. Davies, L. Radican (2015)
A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes MellitusDiabetes Therapy, 6
H. Ishii, JamesH. Anderson, A. Yamamura, M. Takeuchi, I. Ikeda (2008)
Improvement of glycemic control and quality-of-life by insulin lispro therapy: Assessing benefits by ITR-QOL questionnaires.Diabetes research and clinical practice, 81 2
A. Hauber, Hiep Nguyen, J. Posner, I. Kalsekar, J. Ruggles (2016)
A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetesCurrent Medical Research and Opinion, 32
JA Cramer (2004)
1218Diabetes Care, 27
A. Climens, K. Tunceli, B. Arnould, N. Germain, K. Iglay, J. Norquist, K. Brodovicz (2015)
Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapyCurrent Medical Research and Opinion, 31
A. Farmer, L. Rodgers, M. Lonergan, B. Shields, M. Weedon, L. Donnelly, R. Holman, E. Pearson, A. Hattersley (2015)
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care DatabaseDiabetes Care, 39
C. Confavreux, F. Canoui-Poitrine, A. Schott, V. Ambrosi, V. Tainturier, R. Chapurlat (2012)
Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database.European journal of endocrinology, 166 4
Clifford Bailey, Michael Kodack (2011)
Patient adherence to medication requirements for therapy of type 2 diabetesInternational Journal of Clinical Practice, 65
M. Reaney, M. Yu, M. Lakshmanan, V. Pechtner, K. Brunt (2015)
Treatment satisfaction in people with type 2 diabetes mellitus treated with once‐weekly dulaglutide: data from the AWARD‐1 and AWARD‐3 clinical trialsDiabetes, 17
L. García‐Pérez, M. Álvarez, T. Dilla, V. Gil-Guillén, D. Orozco-Beltrán (2013)
Adherence to Therapies in Patients with Type 2 DiabetesDiabetes Therapy, 4
H. Kishimoto, Masayuki Maehara (2015)
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISAArchives of Osteoporosis, 10
H. Ishii, E. Oda (2012)
Reproducibility and validity of a satisfaction questionnaire on hypoglycemic agents: the Oral Hypoglycemic Agent Questionnaire (OHA-Q)Diabetology International, 3
Lei Qin, Stephanie Chen, E. Flood, A. Shaunik, B. Romero, M. Cruz, C. Alvarez, S. Grandy (2017)
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference StudyDiabetes Therapy, 8
P. Evans, S. Bain (2016)
Omarigliptin for the treatment of type 2 diabetes mellitusExpert Opinion on Pharmacotherapy, 17
H. Gelhorn, E. Bacci, J. Poon, K. Boye, Shuichi Suzuki, S. Babineaux (2016)
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in JapanPatient preference and adherence, 10
J. Cramer (2004)
A systematic review of adherence with medications for diabetes.Diabetes care, 27 5
Kathryn Dennick, J. Sturt, J. Speight (2017)
What is diabetes distress and how can we measure it? A narrative review and conceptual model.Journal of diabetes and its complications, 31 5
Q. Qiao, M. Ouwens, S. Grandy, K. Johnsson, K. Kostev (2016)
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in GermanyDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 9
J. Best, Kristina Boye, R. Rubin, Dachuang Cao, T. Kim, M. Peyrot, M. Peyrot (2009)
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily1Diabetic Medicine, 26
A. Hauber, Steven Han, Jui-Chen Yang, I. Gantz, K. Tunceli, J. González, K. Brodovicz, C. Alexander, M. Davies, K. Iglay, Qiaoyi Zhang, L. Radican (2013)
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetesPatient preference and adherence, 7
Lei Qin, Stephanie Chen, E. Flood, A. Shaunik, B. Romero, M. Cruz, C. Alvarez, S. Grandy (2017)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United KingdomDiabetes Therapy, 8
W. Polonsky, L. Fisher, J. Earles, R. Dudl, J. Lees, J. Mullan, R. Jackson (2005)
Assessing psychosocial distress in diabetes: development of the diabetes distress scale.Diabetes care, 28 3
G. Schernthaner (2010)
Fixed‐dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient careDiabetic Medicine, 27
H. Gelhorn, J. Poon, E. Davies, R. Paczkowski, S. Curtis, K. Boye (2015)
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UKPatient preference and adherence, 9
K. Iglay, Xiting Cao, P. Mavros, K. Joshi, Shengsheng Yu, K. Tunceli (2015)
Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy.Clinical therapeutics, 37 8
W. Polonsky, L. Fisher, D. Hessler, D. Bruhn, J. Best (2011)
Patient perspectives on once‐weekly medications for diabetesDiabetes, 13
W. Polonsky, B. Anderson, Patricia Lohrer, G. Welch, A. Jacobson, J. Aponte, C. Schwartz (1995)
Assessment of Diabetes-Related DistressDiabetes Care, 18
Mohammed Ali, K. Bullard, J. Saaddine, C. Cowie, G. Imperatore, E. Gregg (2013)
Achievement of goals in U.S. diabetes care, 1999-2010.The New England journal of medicine, 368 17
M. Kirkman, Megan Rowan-Martin, R. Levin, Vivian Fonseca, J. Schmittdiel, William Herman, Ronald Aubert (2015)
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims DatabaseDiabetes Care, 38
J Thrasher (2017)
S4Am J Cardiol, 120
Emily Peron, K. Ogbonna, Krista Donohoe (2015)
Antidiabetic medications and polypharmacy.Clinics in geriatric medicine, 31 1
L. Blonde, Zinnia Juan (2012)
Fixed-Dose Combinations for Treatment of Type 2 Diabetes MellitusAdvances in Therapy, 29
W. Polonsky, R. Henry (2016)
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsPatient preference and adherence, 10
T. Hampton (2016)
1. Promoting Health and Reducing Disparities in PopulationsDiabetes Care, 40
K. Kaku (2015)
First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitusExpert Opinion on Pharmacotherapy, 16
Celeste Burness, L. Scott (2015)
Dulaglutide: A Review in Type 2 DiabetesBioDrugs, 29
Diabetes Ther (2018) 9:1001–1019 https://doi.org/10.1007/s13300-018-0414-4 ORIGINAL RESEARCH Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) . . . . Hitoshi Ishii Hiroki Shin Takahiro Tosaki Tatsuya Haga . . . Yoshiki Nakajima Toshihiko Shiraiwa Nobuaki Watanabe . . . . Miyuki Koizumi Hiroki Nakajima Sadanori Okada Tsuyoshi Mashitani Takako Mohri Yasuhiro Akai Received: January 16, 2018 / Published online: March 29, 2018 The Author(s) 2018 Treatment Burden Questionnaire (DTBQ), a ABSTRACT patient-administered questionnaire composed of 18 questions, and evaluated its reproducibil- Introduction: To measure the burden of phar- ity and validity. macotherapy on patients with type 2 diabetes Methods: We enrolled 240 patients with T2DM mellitus (T2DM), we developed the Diabetes under pharmacotherapy over 20 years of age at seven institutes in Japan. Their physicians filled Enhanced content To view enhanced content for this out report forms on patient backgrounds, and article go to https://doi.org/10.6084/m9.figshare. the patients answered both the DTBQ and the Diabetes Treatment Satisfaction Questionnaire Electronic supplementary material The online (DTSQ). For evaluation of reproducibility, 48 of version of this article (https://doi.org/10.1007/s13300- 018-0414-4) contains supplementary material, which is the enrolled subjects completed a 2nd DTBQ
Diabetes Therapy – Springer Journals
Published: Mar 29, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.